Two Sigma Investments »

Leap Therapeutics shares owned by Two Sigma Investments

Quarter-by-quarter ownership of Leap Therapeutics (LPTX) shares owned by Two Sigma Investments from 13F filings

Historical chart of Two Sigma Investments investment in Leap Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Leap Therapeutics held by Two Sigma Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Leap Therapeutics by Two Sigma Investments

Quarter filed Position value Share count Share price at filing
2025-09-30 $32k 71k 0.45
2025-06-30 $4.1k 14k 0.30
2025-03-31 $3.9k 13k 0.31
2024-06-30 $46k 23k 1.96

More positions owned by Two Sigma Investments

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Select Sector Spdr Tr Financial (XLF)
Select Sector Spdr Tr Sbi Cons Stpls (XLP)
Vanguard Index Fds Growth Etf (VUG)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Ishares Tr Core S&p500 Etf (IVV)
Rivian Automotive Com Cl A (RIVN)
Palantir Technologies Cl A (PLTR)
NVIDIA Corporation (NVDA)
Micron Technology (MU)
Lockheed Martin Corporation (LMT)
Ishares Tr Rus 1000 Grw Etf (IWF)
Microsoft Corporation (MSFT)
Alnylam Pharmaceuticals (ALNY)

View all positions for Two Sigma Investments

Top funds holding Leap Therapeutics

Gilead Sciences
Acadian Asset Management
Vanguard Group
HighTower Advisors
Simplify Asset Management
Geode Capital Management
Jane Street
Key Client Fiduciary Advisors
State Street Corporation
BlackRock
Hrt Financial
Two Sigma Advisers
Susquehanna International
Citadel Advisors
Two Sigma Investments

View all funds holding Leap Therapeutics